Screening and Confirmation of mecA producing Staphylococcus aureus

 


Purpose: Screening and confirmation of the mecA gene are essential steps in the detection of methicillin-resistant Staphylococcus aureus (MRSA), a bacterium that is resistant to many commonly used antibiotics, including methicillin. The mecA gene is involved in resistance to beta-lactamases by methicillin-resistance in Staphylococcus aureus.

Principle:  The mecA gene is a gene found in bacterial cells. The most commonly known carrier of the mecA gene is the bacterium known as MRSA. The mecA gene allows a bacterium to be resistant to antibiotics such as Methicillin, Penicillin and other penicillin-like antibiotics. The mecA gene does not allow the ring like structure of penicillin-like antibiotics to attack the enzymes that help form the cell wall of the bacterium (transpeptidases), and hence the bacteria is allowed to replicate as normal.

The mecA gene encodes the protein PBP2A (Penicillin binding protein 2A). PBP2A has a low affinity for beta-lactams such as Methicillin, Penicillin and this enables transpeptidase activity in the presence of beta-lactams to allow cell wall synthesis.

It is also found in Streptococcus pneumoniae resistant to penicillins.

Performance characteristics: To identify Methicillin Resistant Staphylococcus aureus.

Required equipment and Reagents:

  1. Muller Hinton Agar
  2. Cefoxitin (30mcg)
  3. Incubator

Procedural steps:

 Sample Collection: Start by collecting a clinical sample, typically from a wound, nasal swab, blood, or other relevant sources, where MRSA is suspected.

Culture and Isolation: The first step is to culture the collected sample on a selective medium incubated at 37±2°C at ambient air in 18-24 hrs that encourages the growth of Staphylococcus aureus. MRSA typically grows on selective media like Mannitol Salt Agar or ChromAgar MRSA.

Gram Staining: Perform a Gram stain to confirm the presence of Gram-positive cocci in clusters, which is characteristic of Staphylococcus species.

 Catalase Test: Perform a catalase test to distinguish Staphylococcus species (positive) from Streptococcus species (negative). MRSA is a Staphylococcus aureus strain.

Screening for Methicillin Resistance:

Disk Diffusion Method: Use the Kirby-Bauer disk diffusion method with a cefoxitin disk (rather than methicillin, which is not widely used anymore).

Molecular Methods (PCR): This is the most specific and reliable method. PCR (Polymerase Chain Reaction) can be used to detect the mecA gene directly from the bacterial DNA. This confirms the presence of mecA and, therefore, methicillin resistance. Alternatively, molecular methods like real-time PCR can be used to detect MRSA-specific genes like mecA.

Confirmation of mecA:

PCR Sequencing: For further confirmation, you can sequence the PCR amplicon to identify the mecA gene specifically.

Other Molecular Tests: There are various other molecular methods and techniques available for confirming mecA, such as PCR with specific primers and probes.

Infection Control Measures: If MRSA is confirmed, implement infection control measures to prevent further transmission within healthcare settings.

Quality control procedures:

Each new batch of medium should be tested with a control organism.

          S. aureus ATCC 25923

Interferences and cross reactions:

If the zone of inhibition is small (usually ≤ 21 mm), it suggests methicillin resistance.

A zone mm of ≤ 21mm is positive and ≥22 mm is negative.

Cefoxitin is used as a surrogate for mecA mediated oxacillin resistance.  Isolates that test as mecA positive are reported as oxacillin resistant; other β-lactam agents should also be considered resistance for clinical therapy.

MRSA SCREENING

Laboratory clinical interpretation:

mecA negative- Report as – Methicillin sensitive Staphylococcus aureus

mecA positive – Report as – Methicillin Resistant Staphylococcus aureus.

Reference:

  1. Clinical and Laboratory Standards Institute (CLSI). Perormance Standards for Antimicrobial susceptibility testing; 12th Informational Supplement. CLSI document M100-S20, Vol 30, No.1. 
  2. Clinical and Laboratory Standards Institute, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898 USA, 2010.


Comments

Popular posts from this blog

Streptococci- Overview of Detection, Identification and Differentiation Techniques

MECHANISMS OF BACTERIAL INTRINSIC DRUG RESISTANCE

India Ink Preparation- Purpose, Principle, Procedure and Result